Enhancing the dissolution rate of mefenamic acid with solid dispersion system using avicel PH-101

Authors

  • Widyasari Putranti Universitas Ahmad Dahlan Indonesia
  • Lina Widiyastuti Fakultas Farmasi, Universitas Ahmad Dahlan
  • Fitri Ulfani Fakultas Farmasi, universitas Ahmad Dahlan

DOI:

https://doi.org/10.12928/pharmaciana.v9i1.10809

Keywords:

avicel PH 101, intrinsic dissolution, mefenamic acid, solid dispersion

Abstract

  Mefenamic acid, based on the Biopharmaceutics Classification System (BCS), is a class II drug that has high permeability but low water solubility. To improve its intrinsic dissolution rate, it is usually combined with a hydrophilic and porous drug carrier like Avicel to create a solid dispersion. This study aimed to enhance the intrinsic dissolution rate of mefenamic acid using a solid dispersion with Avicel PH-101. The test of intrinsic dissolution rate involved a rotational speed of 60 rpm and CO2-free water with a temperature of 37°C as a medium. The interaction of mefenamic acid and Avicel PH-101 was analyzed with FTIR and DSC spectroscopy. The test results showed that the intrinsic dissolution rates (in mg.cm-2.minute-1) of three replications of mefenamic acid, Solid Dispersion of Mefenamic Acid and Avicel PH-101 (SDMA) with 1:1 ratio, SDMA with 1:2 ratio, Physical Mixture of Mefenamic Acid and Avicel PH-101 (PMMA) with 1:1 ratio, and PMMA with 1:2 ratio were (8.0x10-4 ± 3.0x10-4), (38.0x10-4 ± 3.0x10-4), (67.0x10-4 ± 10.0x10-4), (20.0x10-4 ± 6.0x10-4), and (44.0x10-4 ± 14.0x10-4), respectively. The interaction between mefenamic acid and Avicel PH-101 created a hydrogen bonding, as evidenced by the shift in the peaks of FTIR spectra. Based on the DSC thermogram, the mefenamic acid-Avicel PH-101 interaction shifted the steep peak on the curve of mefenamic acid slightly. Avicel PH-101 in this solid dispersion can increase the intrinsic dissolution rate of mefenamic acid through hydrogen bonding instead of decreasing its crystalline structure into an amorphous from.

Author Biography

Widyasari Putranti, Universitas Ahmad Dahlan Indonesia

fakultas farmasi

References

Babu PS and Chowdary KPR, 2008, Enhancement of dissolution rate of celecoxib by solid dispersion in superdisintegrant. Indian Drugs 45:547-552.

Charumanee, S, Okonaki S, Sirithunyalug, J, 2004. Improvement of Dissolution rate of piroxicam by Surface Solid Dispersion. CMU Jurnal 3:77-84.

Coates, J., 2000, Interpretation of Infrared Spectra. A Practical Approach. In Encyclopedia of Analytical Chemistry, in R.A. Meyers (Ed.), pp. 1085-10837, John Wiley & Sons Ltd,Chichester, UK.

Dezani, A.B., Pereira, T.M., Caffaro, A.M., Reis, J.M., Helena, C., Serra, R., 2013, Equilibrium Solubility Versus Intrinsic Dissolution: Characterization of Lamivudin, Stavudine and Zidovudine for BCS Classification, Brazilian Journal of Pharmaceutical Sciences, 49 (4) : 853-863.

Essa A.E, Dwaikat,M. 2015. Enhancement of Simvastatin Dissolution by Surface Solid Dispersion: Effect of Carriers and Wetting Agent, Journal of Applied Pharmaceutical Science Vol. 5 (Suppl 1), pp. 046-053.

Indra and Yulianti, R., 2017 Karakterisasi Padatan Hasil Proses Kokristalisasi Asam Mefenamat menggunakan Metode Penguapan Pelarut, Jurnal Kesehatan Bakti Tunas Husada, 17 (1) : 21-24.

Khatry, S., Sood, N., Arora, S., 2013, Surface Solid Dispersion - A Review, International Journal of Pharmaceutical Sciences and Nanotechnology, 6 (1): 1915-1924.

Khairinnisa, I.N., 2007, Peningkatan Kecepatan Disolusi Intrinsik Ibuprofen melalui Pembentukan Dispersi Padat dengan PEG 6000, Skripsi, Fakultas Farmasi Universitas Ahmad Dahlan.

Krishnaiah, Y.S.R., 2010, Pharmaceutical Technologies for Enhancing Oral Bioavailability of Poorly Soluble Drugs, Journal of Bioequivalence & Bioavailability, 2 (2): 28-33.

Modi, A., and Tayade, P., 2006, Enhancement of Dissolution Profile by Solid Dispersion (Kneading) Technique, American Association of Pharmaceutical Scientist Pharmaceutical Science and Technology, 7 (3): Article 68.

Nerdy, 2017, Validation of Ultraviolet Spectrophotometry Method for Determination of Mefenamic Acid Level in Suspension Dosage Forms, Jurnal Natural, 17 (1): 17-22.

Octavia, M.D., Zaini, E., Oktavia, V., 2015, Studi Sistem Dipersi Padat Asam Mefenamat Menggunakan Polivinilpirolidon K-30, Jurnal Farmasi Higea, 7 (2): 173-180.

Pamudji, J.S., Wikarsa, S., Tampara, M.H., 2014, Improvement of Glicazide’s Dissolution of Rate by Using Surface Solid Dispersion with Avicel PH-101, International Journal of Pharmacy and Pharmaceutical Sciences, 6 (11): 461-465.

Patil, P.B., Gupta, V.R.M., Udupi, R.H., Srikant, K., Prasad, B.S.G., 2010, Development of Dissolution Medium for Poorly Water Soluble Drug Mefenamic Acid, Research Journal of Pharmaceutical, Biological and Chemical Sciences, 1 (4): 546-548.

Pavia, D.L., Lampman, G.M, and Kriz-Jr, G.S., 2009, Introduction to Spectroscopy: A Guide for Student of Organic Chemistry, W.B. Saunders Company, Philadelphia, USA.

Saigal, N., Boboota, S., Ali, J., 2009, Microcrystalline Cellulose as a Versatile Excipient in Drug Research, Journal of Young Pharmacist, 1 (1): 6-12.

Sammour, O.A., Hammad, M.A., Megrab, N.A., Zidan, A.S., 2006, Formulation and Optimization of Mouth Dissolve Tablets Containing Rofecoxib Solid Dispersion, American Association of Pharmaceutical Scientists, 7 (2): 55.

Swathi C.H., Subrahmanyam, C.V.S., Kedarnath, S.A., Babu, P.R.S., 2011, Solubilization of Mefenamic Acid, International Journal of Pharmacy and Technology, 3 (3): 3267-3276.

Vemula, V.R., Lagishetty, V., Lingala, S., 2010, Solubility Enhancement Techniques, International Journal of Pharmaceutical Sciences Review and Research, 5 (1) : 41-46.

Vikram, A., Firoz, S., Kishore, D., Mouli Y.C., Venkataramudu, T., 2012, Formulation and Evaluation of Mefenamic Acid Tablets by Using Modified Starch, Asian Journal of Pharmaceutical Science & Technology, 2 (2): 46-53.

Zaini, E., Putri,V.Z., Octavia M.N., Ismed, F., 2017. Peningkatan Laju disolusi dispersi padat amorf Genistein dengan PVP K-3. Jurnal Sains Farmasi & klinis. 4(2) 67-72.

Downloads

Published

2019-05-23

Issue

Section

Pharmaceutics and Pharmaceutical Technology